glaucoma

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

Protein boosts retinal neuron survival

An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.

Team tracking new options to treat glaucoma

Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.

Glaucoma patients focus of Sousan’s sharing nature

Suzanne Sousan is not afraid of much.

Insights on glaucoma gene mutations

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.

NIH lauds Rex’s ideas for future of vision research

Tonia Rex, Ph.D., assistant professor of Ophthalmology and Visual Sciences at the Vanderbilt Eye Institute, was recently named one of 10 winners of the National Institutes of Health competition for ideas on the future of vision research.

1 2